Xenobiotics: Interaction with the Intestinal Microflora
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
The human body is host to 100 trillion gut microbes, approximately 10-times more than all human cells. It is estimated that the approximately 500-1000 species residing in the human gut encode 150-fold more unique genes than the human genome. The gut microbiota has important functions in metabolic processing, such as energy production, immune cell development, food digestion, and epithelial homeostasis. It has been increasingly recognized that a dysregulated gut microbiome contributes in a significant way to a variety of diseases, including diabetes, obesity, cardiovascular diseases, allergies, and inflammatory bowel disease. In particular, accumulating evidence indicates that functional interactions between the gut microbiome and xenobiotics play a role in mediating chemical toxicity and causing or exacerbating human disease. This review summarizes emerging evidence that illustrates how xenobiotics can affect the gut microbiome structure, create functional changes to the gut microbiome, and become biotransformed by the gut microbiome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597 · cited 2×
“…risk for an adverse cardiovascular event (Tang et al. 2013), which again illustrates how the GM’s interaction with the host can cause disease and which suggests that using probiotics to lessen the GM’s production of TMA (thus also TMAO) may reduce the risk of atherosclerosis (Wang et al. 2011).”
BackgroundThe senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
Diamanti-Kandarakis, E., Bourguignon, J.-P., Giudice, L. C., Hauser, R., Prins, G. S., Soto, A. M., Zoeller, R. T., & Gore, A. C. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0002 · Cited by 4,585
Functional interactions between the gut microbiota and host metabolism
Tremaroli, V., & Bäckhed, F. (2012) · Nature · doi:10.1038/nature11552 · Cited by 4,387 · cited 3×
“This suggests that the gut microbiota can regulate gut permeability (Tremaroli and Backhed 2012), suggesting that the composition of the GM can play a role in the development of diabetes.”
BackgroundResultInfluentialThe gut microbiota--masters of host development and physiology
Sommer, F., & Bäckhed, F. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro2974 · Cited by 3,681
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk
Tang, W. H. W., Wang, Z., Levison, B. S., Koeth, R. A., Britt, E. B., Fu, X., Wu, Y., & Hazen, S. L. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1109400 · Cited by 3,400
Vrieze, A., Van Nood, E., Holleman, F., Salojärvi, J., Kootte, R. S., Bartelsman, J. F. W. M., Dallinga–Thie, G. M., Ackermans, M. T., Serlie, M. J., Oozeer, R., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.031 · Cited by 2,913
Gut–brain axis: How the microbiome influences anxiety and depression
Foster, J. A., & McVey Neufeld, K.-A. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2013.01.005 · Cited by 2,460
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
Yoshimoto, S., Loo, T. M., Atarashi, K., Kanda, H., Sato, S., Oyadomari, S., Iwakura, Y., Oshima, K., Morita, H., Hattori, M., et al. (2013) · Nature · doi:10.1038/nature12347 · Cited by 2,219
Exercise and associated dietary extremes impact on gut microbial diversity
Clarke, S. F., Murphy, E. F., O'Sullivan, O., Lucey, A. J., Humphreys, M., Hogan, A., Hayes, P., O'Reilly, M., Jeffery, I. B., Wood-Martin, R., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-306541 · Cited by 1,439 · cited 1×
“However, the relationship between exercise and the gut microbiome is complex (Clarke et al. 2014), and it is unclear if exercise would attenuate the effects of other kinds of chemical exposure on the gut microbiome similar to what was observed for PCBs.”
BackgroundDumas, M.-E., Barton, R. H., Toye, A., Cloarec, O., Blancher, C., Rothwell, A., Fearnside, J., Tatoud, R., Blanc, V., Lindon, J. C., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601056103 · Cited by 1,042 · cited 5×
“Another major disease in which the GM is implicated is nonalcoholic fatty liver disease (NAFLD).”
BackgroundInfluentialGut microbiome, obesity, and metabolic dysfunction
Tilg, H., & Kaser, A. (2011) · Journal of Clinical Investigation · doi:10.1172/jci58109 · Cited by 860 · cited 3×
“The GM is integral to metabolic processes through the regulation of metabolism-modulating host genes (e.g., Fiaf and Gpr41 in murine models) (Tilg and Kaser 2011) and the direct fermentation of nondigestible dietary carbohydrates into metabolites such as the short-chain fatty acids (SCFAs)…”
BackgroundInfluentialXenobiotics shape the physiology and gene expression of the active human gut microbiome
Maurice, C. F., Haiser, H. J., & Turnbaugh, P. J. (2013) · Cell · doi:10.1016/j.cell.2012.10.052 · Cited by 811 · cited 6×
“Out of these gene clusters, therewas an upregulation in genes related to stress response and antibiotic resistance, suggesting that antibiotic exposure creates metabolic stress aswell as selective pressure, which changes how the GM responds to environmental exposure (Maurice et al. 2013).”
BackgroundInfluentialParracho, H. M., Bingham, M. O., Gibson, G. R., & McCartney, A. L. (2005) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46101-0 · Cited by 784 · cited 2×
“Clostridia are known toproduceneurotoxins,whichcould furtherworsen the behavioral symptoms of autism (Parracho et al. 2005).”
BackgroundPredicting and Manipulating Cardiac Drug Inactivation by the Human Gut Bacterium Eggerthella lenta
Haiser, H. J., Gootenberg, D. B., Chatman, K., Sirasani, G., Balskus, E. P., & Turnbaugh, P. J. (2013) · Science · doi:10.1126/science.1235872 · Cited by 704 · cited 2×
“A recent study has elucidated a mechanism involved in the metabolism of digoxin by showing the upregulation of a two-gene cytochrome-encoding operon in E. lenta that was co-administered with digoxin (Haiser et al. 2013).”
BackgroundThe gastrointestinal microbiota as a site for the biotransformation of drugs
Sousa, T., Paterson, R., Moore, V., Carlsson, A., Abrahamsson, B., & Basit, A. W. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.07.009 · Cited by 618 · cited 5×
“One paper identified 30 drugs whose biotransformation is mediated by the GM (Sousa et al. 2008), while other publications have discussed other drugs (Davey et al. 2012; Kang et al. 2013).”
BackgroundMethodInfluentialWilliams, B. L., Hornig, M., Buie, T., Bauman, M. L., Cho Paik, M., Wick, I., Bennett, A., Jabado, O., Hirschberg, D. L., & Lipkin, W. I. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024585 · Cited by 492 · cited 2×
“a result of an autistic disease state (Benach et al. 2012; Williams et al. 2011).”
BackgroundInactivation of Digoxin by the Gut Flora: Reversal by Antibiotic Therapy
Lindenbaum, J., Rund, D. G., Butler, V. P., Tse-Eng, D., & Saha, J. R. (1981) · New England Journal of Medicine · doi:10.1056/nejm198110013051403 · Cited by 423 · cited 1×
“Digoxin was found to be inactivated by the GM into reduced metabolites that were unable to have any medical effect (Lindenbaum et al. 1981).”
BackgroundAltered brain-gut axis in autism: comorbidity or causative mechanisms
Mayer, E. A., Padua, D., & Tillisch, K. (2014) · BioEssays · doi:10.1002/bies.201400075 · Cited by 304 · cited 1×
“Still, as the bulk of the studies are correlational and the underlyingmechanisms are not largely understood, several researchers agree that more studies are needed to better elucidate the role of the gut microbiome in autism (Mayer et al. 2014; Toh and Allen-Vercoe 2015).”
BackgroundExercise Attenuates PCB-Induced Changes in the Mouse Gut Microbiome
Choi, J. J., Eum, S. Y., Rampersaud, E., Daunert, S., Abreu, M. T., & Toborek, M. (2013) · Environmental Health Perspectives · doi:10.1289/ehp.1306534 · Cited by 298 · cited 5×
“2% from baseline) and primarily decreased the levels of proteobacteria (Choi et al. 2013).”
BackgroundInfluentialThe Gut Microbiome: A New Frontier in Autism Research
Mulle, J. G., Sharp, W. G., & Cubells, J. F. (2013) · Current Psychiatry Reports · doi:10.1007/s11920-012-0337-0 · Cited by 262
Digoxin-Inactivating Bacteria: Identification in Human Gut Flora
Dobkin, J. F., Saha, J. R., Butler, V. P., Neu, H. C., & Lindenbaum, J. (1983) · Science · doi:10.1126/science.6836275 · Cited by 259
Formation of methylamines from ingested choline and lecithin.
Zeisel, S. H., Wishnok, J. S., & Blusztajn, J. K. (1983) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)33590-1 · Cited by 253
Intestinal Microbiota Regulate Xenobiotic Metabolism in the Liver
Björkholm, B., Bok, C. M., Lundin, A., Rafter, J., Hibberd, M. L., & Pettersson, S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006958 · Cited by 249 · cited 1×
“On another note, recent studies have shown how the GM can indirectly regulate xenobiotic metabolism in the liver (Bjorkholm et al. 2009; Meinl et al. 2009), which means that the gut microbiome may not have to “see” a particular metabolite in order to be able to affect its metabolism.”
BackgroundDavey, K. J., Cotter, P. D., O'Sullivan, O., Crispie, F., Dinan, T. G., Cryan, J. F., & O'Mahony, S. M. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.83 · Cited by 236
Ecotoxicology inside the gut: impact of heavy metals on the mouse microbiome
Breton, J., Massart, S., Vandamme, P., De Brandt, E., Pot, B., & Foligné, B. (2013) · BMC Pharmacology and Toxicology · doi:10.1186/2050-6511-14-62 · Cited by 213
Haiser, H. J., Seim, K. L., Balskus, E. P., & Turnbaugh, P. J. (2014) · Gut Microbes · doi:10.4161/gmic.27915 · Cited by 197 · cited 2×
“This cardiac glycoside reductase (cgr) operon is thought to produce a protein (known as Cgr1-Cgr2 complex) that can bind to digoxin and cause the formation of reduced metabolites like dihydrodigoxin (Haiser et al. 2014).”
BackgroundMaharshak, N., Packey, C. D., Ellermann, M., Manick, S., Siddle, J. P., Huh, E. Y., Plevy, S., Sartor, R. B., & Carroll, I. M. (2013) · Gut Microbes · doi:10.4161/gmic.25486 · Cited by 174 · cited 2×
“…study, we found that arsenic-exposed, immunocompromised IL-10−/− mice (which were associated with a decrease in GM diversity in previous studies [Maharshak et al. 2013]) showed an increase in MMAV, iAsV, and the ratio of MMAV/DMAV, suggesting that an abnormal genetic background is another…”
BackgroundUrinary p-cresol is elevated in small children with severe autism spectrum disorder
Altieri, L., Neri, C., Sacco, R., Curatolo, P., Benvenuto, A., Muratori, F., Santocchi, E., Bravaccio, C., Lenti, C., Saccani, M., et al. (2011) · Biomarkers · doi:10.3109/1354750x.2010.548010 · Cited by 161 · cited 1×
“Yet another study found an increase in the gut-microbialmetabolite p-cresol in autistic children comparedwith controls, further implicating the involvement of the gut microbiome in autism (Altieri et al. 2011).”
Joly, C., Gay-Quéheillard, J., Léké, A., Chardon, K., Delanaud, S., Bach, V., & Khorsi-Cauet, H. (2013) · Environmental Science and Pollution Research · doi:10.1007/s11356-012-1283-4 · Cited by 135 · cited 2×
“This is interesting because these two species are considered to be probiotic; thus their decrease is a sign ofmicrobial dysbiosis that could further lead to disease (Joly et al. 2013).”
BackgroundNakayama, H., Kinouchi, T., Kataoka, K., Akimoto, S., Matsuda, Y., & Ohnishi, Y. (1997) · Pharmacogenetics · doi:10.1097/00008571-199702000-00005 · Cited by 120 · cited 3×
“Later studies in a rat model provided a possible mechanism for this unfortunate outcome: the gut-microbial metabolite bromvalerylurea (BVU) is reduced in the liver by an enzyme known as dihydropyrimidine dehydrogenase (DPD).”
BackgroundGut microbiota and inflammatory bowel disease: the role of antibiotics in disease management
Kerman, D. H., & Deshpande, A. R. (2014) · Postgraduate Medicine · doi:10.3810/pgm.2014.07.2779 · Cited by 47
Cited by
Gut instincts: microbiota as a key regulator of brain development, ageing and neurodegeneration
Dinan, T. G., & Cryan, J. F. (2017) · The Journal of Physiology · doi:10.1113/jp273106 · Cited by 813
“A growing body of literature is now focusing on the collateral impact of various medications outside of CNS drugs on microbiome composition (Lu et al. 2015; Spanogiannopoulos et al. 2016).”
BackgroundMicrobial regulation of organismal energy homeostasis
Cani, P. D., Van Hul, M., Lefort, C., Depommier, C., Rastelli, M., & Everard, A. (2019) · Nature Metabolism · doi:10.1038/s42255-018-0017-4 · Cited by 569
The Microbiota–Gut–Brain Axis in Psychiatric Disorders
Góralczyk-Bińkowska, A., Szmajda-Krygier, D., & Kozłowska, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911245 · Cited by 495
Gut reactions: Breaking down xenobiotic–microbiome interactions
Clarke, G., Sandhu, K. V., Griffin, B. T., Dinan, T. G., Cryan, J. F., & Hyland, N. P. (2019) · Pharmacological Reviews · doi:10.1124/pr.118.015768 · Cited by 319
“Heavy metals such as mercury, lead, cadmium, and arsenic may also have an important impact on the gut microbiota (Lu et al., 2015).”
BackgroundMicrobiota effects on cancer: From risks to therapies
Rea, D., Coppola, G., Palma, G., Barbieri, A., Luciano, A., Del Prete, P., Rossetti, S., Berretta, M., Facchini, G., Perdonà, S., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24681 · Cited by 208
“Several internal and external factors can influence this population growth including age, race, diet, maternal colonization, as well as environmental exposures to xenobiotics and antibiotics [6].”
Background
Metadata
- Authors
- Lu, K., Mahbub, R., & Fox, J. G.
- Venue
- ILAR Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-08-31
- Volume
- 56
- Issue
- 2
- Pages
- 218-227
- ISSN
- 1084-2020 (ISSN-L)
- 1930-6180
- OpenAlex
- W1938579688
- Cited by
- 117
- References
- 32
- FWCI
- 3.73
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.